Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.
In this clinical trial, we aimed to compare three means of performing chronic hemodialysis in patients with contra-indication to systemic heparinization.This open-label monocentric randomized « n-of-one » trial, conducted in a single tertiary care center, recruited chronic hemodialysis patients with...
Main Authors: | Bruno Guéry, Corinne Alberti, Aude Servais, Elarbi Harrami, Lynda Bererhi, Brigitte Zins, Malik Touam, Dominique Joly |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4019548?pdf=render |
Similar Items
-
Hemodialysis without Systemic Anticoagulation: A Randomized Controlled Trial to Evaluate Five Strategies in Patients at a High Risk of Bleeding
by: Pedro H. Franca Gois, et al.
Published: (2024-08-01) -
Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies
by: Ting Lin, et al.
Published: (2019-12-01) -
Anticoagulants and Gastrointestinal Bleeding
by: Mark Crowther, et al.
Published: (2005-01-01) -
Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare
by: Robert Boggs, PhD, et al.
Published: (2023-02-01) -
Bleeding issues in women prescribed anticoagulation
by: V. Speed, et al.
Published: (2021-12-01)